June 12, 2019
Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon). Read the Press Release
June 07, 2019
Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer. Read the Press Release
May 22, 2019
Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States. Read the Press Release
May 22, 2019
Biophytis announces the resumption of the listing of its stock on May 23, 2019, at the opening of the markets. Read the press release
May 22, 2019
Biophytis announces the publication of its 2018 Reference Document. Read the press release
May 22, 2019
Biophytis announces suspension of trading until distribution of a press release. Read the Press Release
May 2, 2019
Biophytis Presented A Poster at The Association for Research in Vision and Ophthalmology Annual Meeting. Read the Press Release
April 17, 2019
Interview with Stanislas Veillet, CEO of Biophytis, on the Web TV
April 16, 2019
Biophytis announces the release of the 2018 Annual Financial Report and the departure of Jean-Gérard Galvez from the Board of Directors. Read the Press Release
April 04, 2019
Biophytis to participate in several investors’ events during the month of April. Read the Press Release